Stay updated with breaking news from Marc Thill. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The final data set from NeoDynamics’ PULSE study shows favorable safety and efficacy profile of NeoNavia for ultra-sound guided biopsies in the axillary lymph nodes. The data are being presented... | May 5, 2023
/PRNewswire/ -- Data from the NeoDynamics' PULSE study with its biopsy device NeoNavia shows a success rate of 96% in very complex and risky axilla biopsies....
/PRNewswire/ -- NeoDynamics AB (Spotlight Stock Market: NEOD), a medtech company dedicated to advancing diagnosis and care of breast cancer, will present...
/PRNewswire/ -- NeoDynamics AB (Spotlight Stock Market: NEOD), a medtech company dedicated to advancing diagnosis and care of breast cancer, will present...
NeoDynamics presents an abstract on pulse biopsy data for NeoNavia at the UK Association of Breast Surgeons Conference 2021 News provided by Share this article Share this article STOCKHOLM, May 17, 2021 /PRNewswire/ -- NeoDynamics AB (Spotlight Stock Market: NEOD), a MedTech company dedicated to advancing diagnosis and care of breast cancer, presents pre-clinical data in a poster session at the Association of Breast Surgeons (ABS) online Conference 2021, May 16th – 18th. The data presented in the abstract demonstrates that NeoDynamics FlexiPulse needle outperforms standard core needle biops...